SCM
CGEM icon

Sterling Capital Management’s Cullinan Oncology CGEM Stock Holding History

Sterling Capital Management’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.2K Sell
1,219
-580
-32% -$8.61K ﹤0.01% 1844
2026
Q1 		$25.6K Sell
1,799
-1,272
-41% -$16.3K ﹤0.01% 1905
2025
Q4 		$31.8K Sell
3,071
-449
-13% -$4.05K ﹤0.01% 1990
2025
Q3 		$20.9K Buy
3,520
+2,143
+156% +$15.7K ﹤0.01% 2115
2025
Q2 		$10.4K Buy
1,377
+1,231
+843% +$9.89K ﹤0.01% 2110
2025
Q1 		$1.1K Sell
146
-96
-40% -$921 ﹤0.01% 2782
2024
Q4 		$2.95K Buy
242
+183
+310% +$2.63K ﹤0.01% 2656
2024
Q3 		$988 Buy
+59
New +$1.05K ﹤0.01% 2534

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Sterling Capital Management's CGEM Position: Q2 2026 in Review

Sterling Capital Management reduced its Cullinan Oncology (CGEM) stake by 32% in Q2 2026, selling an estimated $8.61K and leaving 1,219 shares worth $22.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1844.

Sterling Capital Management first reported a position in CGEM in Q3 2024 and has held it in 8 quarters since. The position peaked at $31.8K in Q4 2025. 184 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Sterling Capital Management held 1,219 shares of Cullinan Oncology worth $22.2K as of Q2 2026.
  • Sterling Capital Management sold 580 Cullinan Oncology shares in Q2 2026, an estimated $8.61K.
  • Cullinan Oncology made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #1844 holding.
  • Sterling Capital Management first reported a position in Cullinan Oncology in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's Cullinan Oncology position peaked at $31.8K in Q4 2025.
  • 184 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.